M. Petrek (Olomouc, Czech Republic), L. Nicod (Bern, Switzerland)
Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis
A. Ricci, S. Mariotta, E. Cherubini, L. Tabi‘, L. Pisani, P. Bruno, S. Sciacchitano (Rome, Italy)
|  |
Nanoparticle-assisted gene delivery in a bleomycin-injured lung fibrosis model
C. von Garnier, A. Gazdhar, A. Fink, H. Hofmann, L. Nicod, T. Geiser (Berne, Lausanne, Switzerland)
|  |
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
A. Proklou, K. Antoniou, G. Soufla, F. Economidou, K. Samara, M. Manousakis, I. Drositis, D. Spandidos, N. Siafakas (Heraklion, Greece)
| |
Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
K. Antoniou, H. Papadaki, G. Soufla, A. Darivianaki, H. Koutala, M. C. Kastrinaki, D. Spandidos, N. Siafakas (Herarklion, Heraklion, Greece)
| |
NIR spectroscopy of penetrating light and its diagnostic value in idiopatic pulmonary
J. Votruba, T. Bruha, T. Baláz (Prague, Brno, Czech Republic)
|  |
A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis
M. Veltkamp, J. Grutters, C. van Moorsel, G. Rijkers, H. Ruven, J. van den Bosch (Nieuwegein, Nieuwgein, Netherlands)
| |
Chemokine mRNA expression profiling in pulmonary sarcoidosis
E. Kriegova, R. Fillerova, A. Arakelyan, F. Mrazek, B. Hutyrova, V. Kolek, R. du Bois, M. Petrek (Olomouc, Czech Republic; Denver, CO, United States Of America)
| |
Frequency of beryllium and mycobacterial specific blood CD4+ T-cells in patients with sarcoidosis
L. Cervis, G. Zissel, N. Lutzen, J. Muller-Quernheim, A. Prasse (Bucharest, Romania; Freiburg, Germany)
| |